Inovio Pharmaceuticals, Inc.INONASDAQ
Loading
Year-over-year revenue growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P49
Within normal range
Average
140.88%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 0.00% |
| Q2 2025 | -100.00% |
| Q1 2025 | -44.15% |
| Q4 2024 | 0.00% |
| Q3 2024 | -100.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | -100.00% |
| Q4 2023 | -73.57% |
| Q3 2023 | 71.90% |
| Q2 2023 | 96.59% |
| Q1 2023 | -7.80% |
| Q4 2022 | -98.64% |
| Q3 2022 | 1067.03% |
| Q2 2022 | 294.02% |
| Q1 2022 | -76.28% |
| Q4 2021 | 187.67% |
| Q3 2021 | 6.92% |
| Q2 2021 | -26.49% |
| Q1 2021 | -93.35% |
| Q4 2020 | 2262.87% |
| Q3 2020 | -11.61% |
| Q2 2020 | -79.87% |
| Q1 2020 | 374.89% |
| Q4 2019 | -67.76% |
| Q3 2019 | 538.94% |
| Q2 2019 | -95.21% |
| Q1 2019 | 13.08% |
| Q4 2018 | 25.08% |
| Q3 2018 | -91.82% |
| Q2 2018 | 1498.33% |
| Q1 2018 | -82.59% |
| Q4 2017 | 232.28% |
| Q3 2017 | -87.04% |
| Q2 2017 | 96.72% |
| Q1 2017 | 21.87% |
| Q4 2016 | -32.11% |
| Q3 2016 | 102.14% |
| Q2 2016 | -23.51% |
| Q1 2016 | 36.64% |